Oncolytics Biotech Inc (ONCY)
1.06
+0.03
(+2.91%)
USD |
NASDAQ |
Mar 28, 16:00
1.05
-0.01
(-0.94%)
After-Hours: 20:00
Oncolytics Biotech Total Assets (Quarterly): 29.26M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 29.26M |
September 30, 2023 | 33.91M |
June 30, 2023 | 24.12M |
March 31, 2023 | 26.12M |
December 31, 2022 | 27.51M |
September 30, 2022 | 28.49M |
June 30, 2022 | 31.23M |
March 31, 2022 | 35.60M |
December 31, 2021 | 35.98M |
September 30, 2021 | 41.23M |
June 30, 2021 | 45.41M |
March 31, 2021 | 42.92M |
December 31, 2020 | 26.93M |
September 30, 2020 | 23.34M |
June 30, 2020 | 25.34M |
March 31, 2020 | 24.36M |
December 31, 2019 | 15.05M |
September 30, 2019 | 12.30M |
June 30, 2019 | 11.66M |
March 31, 2019 | 12.33M |
December 31, 2018 | 10.91M |
September 30, 2018 | 14.05M |
June 30, 2018 | 15.61M |
March 31, 2018 | 10.94M |
December 31, 2017 | 14.43M |
Date | Value |
---|---|
September 30, 2017 | 11.94M |
June 30, 2017 | 13.52M |
March 31, 2017 | 7.966M |
December 31, 2016 | 10.95M |
September 30, 2016 | 14.02M |
June 30, 2016 | 16.52M |
March 31, 2016 | 17.74M |
December 31, 2015 | 19.73M |
September 30, 2015 | 23.09M |
June 30, 2015 | 26.74M |
March 31, 2015 | 24.80M |
December 31, 2014 | 14.81M |
September 30, 2014 | 16.20M |
June 30, 2014 | 18.79M |
March 31, 2014 | 20.84M |
December 31, 2013 | 26.51M |
September 30, 2013 | 31.55M |
June 30, 2013 | 37.47M |
March 31, 2013 | 43.57M |
December 31, 2012 | 22.19M |
September 30, 2012 | 29.65M |
June 30, 2012 | 35.78M |
March 31, 2012 | 47.52M |
December 31, 2011 | 35.29M |
September 30, 2011 | 41.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.66M
Minimum
Jun 2019
45.41M
Maximum
Jun 2021
27.65M
Average
27.22M
Median
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 7.832M |
Lexaria Bioscience Corp | 3.627M |
Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 8.486M |
Shareholders Equity (Quarterly) | 20.78M |